Biased Ligands. Better Drugs.

Biased Ligand Products

Cardiovascular Program

Although Trevena's biased GPCR ligand technology is potentially applicable across a wide range of drug targets and diseases, our pipeline of wholly owned differentiated biased ligand drugs is currently focused on CNS diseases.

Recent Product News

Related Events

Copyright © Trevena, Inc.